Back to Journals » Drug Design, Development and Therapy » Volume 17

Original Research

UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway

       
Total article views   HTML views PDF downloads Totals
2,998 Dovepress* 2,721+ 89 2,810
PubMed Central* 277 136 413
Totals 2,998 225 3,223
*Since 5 May 2023

View citations on PubMed Central and Google Scholar